Back

The prevalence of cardiac troponin autoantibodies is comparable in cardiac patients and healthy individuals and irrespective of age, sex and comorbidities

30 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Cardiac troponins in 2026: diagnostic accuracy, biological variation, and clinical decision-making Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Helea Junes

University of Turku, Turku (Finland)

6 More presentations in this session

Presentation thumbnail
What is the diagnostic accuracy of different high sensitive point-of-care troponin assays for the assessments of patients presenting with chest pain at the emergency department?
Miss B. Backus (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Performance of the novel high-sensitivity cardiac troponin T- Generation 6 assay in the early diagnosis of myocardial infarction in patients with prior coronary artery bypass grafting
Doctor L. Koechlin (Zurich, CH)
Abstract Slides
Presentation thumbnail
Initial versus peak high-sensitivity troponin T for risk stratification in STEMI
Doctor M. Habib (Doha, QA)
Abstract Slides
Presentation thumbnail
Age-specific 99th percentile of high-sensitivity cardiac troponin I
Mrs I. Ortega Posch (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Towards a more robust estimation of the decision threshold for high-sensitivity cardiac troponins
Miss S. Lamers (Maastricht, NL)
Abstract Slides

Access the full session

Session thumbnail
Cardiac troponins in 2026: diagnostic accuracy, biological variation, and clinical decision-making

The Event

Event poster

ESC Congress 2026

30 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac troponin autoantibodies in breast cancer patients receiving adjuvant cardiotoxic chemotherapy: the PRADA study
20 June 2025
thumbnail
Congress Presentation
The real-life prevalence and risk factors of elevated CRP in patients from cardiology outpatient clinics. The results from the STAR-Lp(a) study.
1 September 2025
thumbnail
Congress Presentation
Prevalence of cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation
22 May 2023
thumbnail
Congress Presentation
High frequency of macrotroponin i in the upper troponin range of a healthy reference population but no variation by age or sex
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources